Third Phase

A COVID-19 vaccine candidate developed by China's WestVac Biopharma Co Ltd has received a nod from the Nepali authorities to conduct third-phase clinical trials in the South Asian country, the Nepali government officials said.

With the completion of the second phase of works related to the Bheri-Babai Multi-purpose Diversion Project, the third phase of works has begun.